Evidence map›Paper›PMID 34380554›Full record

ArticleParasites & vectors2021

Urine metabolites for the identification of Onchocerca volvulus infections in patients from Cameroon.

Vera Wewer, Helga Peisker, Katharina Gutbrod, Mazen Al-Bahra, Dirk Menche, Ngongeh Glory Amambo, Fanny F Fombad, Abdel Jelil Njouendou, Kenneth Pfarr, Samuel Wanji and 2 more

Open access · goldAbstract read
In one paragraph

Article in Parasites & vectors, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Identification and Characterization ofPathogens (Basel, Switzerland) · 2024
    Article
  3. Article
  4. Whole blood transcriptome analysis in onchocerciasis.Current research in parasitology & vector-borne diseases · 2022
    Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Vera WewerInstitute of Medical Microbiology, Immunology and Parasitology (IMMIP), University Hospital Bonn, Venusberg-Campus 1, 53127, Bonn, Germany.
Helga PeiskerInstitute of Molecular Physiology and Biotechnology of Plants, University of Bonn, Karlrobert-Kreiten-Str. 13, 53115, Bonn, Germany.
Katharina GutbrodInstitute of Molecular Physiology and Biotechnology of Plants, University of Bonn, Karlrobert-Kreiten-Str. 13, 53115, Bonn, Germany.
Mazen Al-BahraKekulé-Institute of Organic Chemistry and Biochemistry, University of Bonn, Gerhard-Domagk-Str. 1, 53121, Bonn, Germany.
Dirk MencheKekulé-Institute of Organic Chemistry and Biochemistry, University of Bonn, Gerhard-Domagk-Str. 1, 53121, Bonn, Germany.
Ngongeh Glory AmamboResearch Foundation for Tropical Diseases and the Environment (REFOTDE), Buea, Cameroon.
Fanny F FombadResearch Foundation for Tropical Diseases and the Environment (REFOTDE), Buea, Cameroon.
Abdel Jelil NjouendouResearch Foundation for Tropical Diseases and the Environment (REFOTDE), Buea, Cameroon.
Kenneth PfarrInstitute of Medical Microbiology, Immunology and Parasitology (IMMIP), University Hospital Bonn, Venusberg-Campus 1, 53127, Bonn, Germany. kenneth.pfarr@ukbonn.de.ORCID http://orcid.org/0000-0003-3096-2465
Samuel WanjiResearch Foundation for Tropical Diseases and the Environment (REFOTDE), Buea, Cameroon.
Achim HoeraufInstitute of Medical Microbiology, Immunology and Parasitology (IMMIP), University Hospital Bonn, Venusberg-Campus 1, 53127, Bonn, Germany. achim.hoerauf@ukbonn.de.
Peter DörmannInstitute of Molecular Physiology and Biotechnology of Plants, University of Bonn, Karlrobert-Kreiten-Str. 13, 53115, Bonn, Germany. doermann@uni-bonn.de.ORCID http://orcid.org/0000-0002-5845-9370
University of Bonn · DEUniversity of Buea · CMUniversity Hospital Bonn · DEUniversity of Cologne · DE

Funding

Bill and Melinda Gates Foundation OPP1083888Deutsche Forschungsgemeinschaft TRR 261Deutsches Zentrum für Infektionsforschung TI 03.907
6 · The paper itself

Abstract

backgroundThe tropical disease onchocerciasis (river blindness), caused by Onchocerca volvulus filarial nematodes, is targeted for elimination by mass treatment with nematocidal and antimicrobial drugs. Diagnosis of O. volvulus infections is based on counts of skin-borne microfilariae, but additional diagnostic tools, e.g. worm- or host-derived small RNAs, proteins or metabolites, are required for high-throughput screening. N-acetyltyramine-O,β-glucuronide (NATOG) was suggested as a biomarker for onchocerciasis but its viability as diagnostic tool has been challenged.

methodsWe performed a screening program of urine samples from individuals from Cameroon infected with O. volvulus, Loa loa, Mansonella perstans or a combination thereof. Urine metabolites were measured by liquid chromatography-mass spectrometry (LC-MS). Principle component analysis (PCA) revealed that onchocerciasis causes complex changes of the urine metabolome.

resultsThe mean NATOG content was elevated in urine of O. volvulus-infected compared with non-infected individuals, but NATOG levels showed considerable variation. However, 13.8% of all O. volvulus-infected individuals had high NATOG levels never reached by individuals without filarial infections or only infected with L. loa or M. perstans. Therefore, the identification of individuals with high NATOG levels might be used to screen for the elimination of onchocerciasis after mass drug application. Additional metabolites, including a compound identified as cinnamoylglycine, had high PC1/PC2 loadings in the data set. Mean levels of cinnamoylglycine were increased in O. volvulus-infected individuals, and 17.2% of all O. volvulus individuals had elevated cinnamoylglycine levels not reached by the controls.

conclusionsOn an individual level, NATOG alone had poor discriminative power distinguishing infected from non-infected individuals. However, 13.8% of all O. volvulus-infected individuals had NATOG levels never reached by individuals without filarial infections or infected with only L. loa or M. perstans. Discrimination of O. volvulus infections from controls or individuals suffering from multiple infections was improved by the measurement of additional metabolites, e.g. cinnamoylglycine. Thus, measuring a combination of urine metabolites may provide a way to assess onchocerciasis on the population level. This provides the possibility to design a strategy for large-scale onchocerciasis epidemiological screening programs based on urine rather than invasive techniques.

Indexed as

MetabolomeAnimalsBiomarkersCameroonChromatography, LiquidGlucuronidesGlycineHumansMass SpectrometryOnchocerca volvulusOnchocerciasisOnchocerciasis, OcularBiomarkerscinnamoylglycineGlucuronidesGlycineDiagnosisFilariasisMass spectrometryMetaboliteNATOGOnchocerca volvulusOnchocerciasis

Identifiers

PMID34380554
PMCPMC8359580
OpenAlexW3191465345

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.